The clinical potential of HMGB1 for the risk assessment of severe checkpoint inhibitor pneumonitis: A prospective multicenter study (CS-Lung004)

Authors:

Abstract
No abstract available
Funding Information
  • Japan Agency for Medical Research and Development

This publication has 28 references indexed in Scilit: